The global Belimumab market size was valued at US$ 1.12 billion in 2024 and is projected to reach US$ 1.78 billion by 2030, at a CAGR of 8.0% during the forecast period 2024-2030.
United States Belimumab market size was valued at US$ 543 million in 2024 and is projected to reach US$ 847 million by 2030, at a CAGR of 7.7% during the forecast period 2024-2030.
Belimumab is a monoclonal antibody targeting B-lymphocyte stimulator, used in the treatment of Systemic Lupus Erythematosus.
Strong growth supported by expanding indications and formulations. Increasing adoption as add-on therapy in SLE treatment. Potential for use in other autoimmune disorders driving future market prospects.
Report Overview
This report provides a deep insight into the global Belimumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Belimumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Belimumab market in any manner.
Global Belimumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Market Segmentation (by Type)
- 400mg Injection
- 120mg Injection
Market Segmentation (by Application)
- Hospital
- Drug Center
- Clinic
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Belimumab Market
- Overview of the regional outlook of the Belimumab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Belimumab
1.2 Key Market Segments
1.2.1 Belimumab Segment by Type
1.2.2 Belimumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Belimumab Market Overview
2.1 Global Market Overview
2.1.1 Global Belimumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Belimumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Belimumab Market Competitive Landscape
3.1 Global Belimumab Sales by Manufacturers (2019-2024)
3.2 Global Belimumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Belimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Belimumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Belimumab Sales Sites, Area Served, Product Type
3.6 Belimumab Market Competitive Situation and Trends
3.6.1 Belimumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Belimumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Belimumab Industry Chain Analysis
4.1 Belimumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Belimumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Belimumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Belimumab Sales Market Share by Type (2019-2024)
6.3 Global Belimumab Market Size Market Share by Type (2019-2024)
6.4 Global Belimumab Price by Type (2019-2024)
7 Belimumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Belimumab Market Sales by Application (2019-2024)
7.3 Global Belimumab Market Size (M USD) by Application (2019-2024)
7.4 Global Belimumab Sales Growth Rate by Application (2019-2024)
8 Belimumab Market Segmentation by Region
8.1 Global Belimumab Sales by Region
8.1.1 Global Belimumab Sales by Region
8.1.2 Global Belimumab Sales Market Share by Region
8.2 North America
8.2.1 North America Belimumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Belimumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Belimumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Belimumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Belimumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Belimumab Basic Information
9.1.2 GlaxoSmithKline Belimumab Product Overview
9.1.3 GlaxoSmithKline Belimumab Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Belimumab SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
10 Belimumab Market Forecast by Region
10.1 Global Belimumab Market Size Forecast
10.2 Global Belimumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Belimumab Market Size Forecast by Country
10.2.3 Asia Pacific Belimumab Market Size Forecast by Region
10.2.4 South America Belimumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Belimumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Belimumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Belimumab by Type (2025-2030)
11.1.2 Global Belimumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Belimumab by Type (2025-2030)
11.2 Global Belimumab Market Forecast by Application (2025-2030)
11.2.1 Global Belimumab Sales (Kilotons) Forecast by Application
11.2.2 Global Belimumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Belimumab Market Size Comparison by Region (M USD)
Table 5. Global Belimumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Belimumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Belimumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Belimumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Belimumab as of 2022)
Table 10. Global Market Belimumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Belimumab Sales Sites and Area Served
Table 12. Manufacturers Belimumab Product Type
Table 13. Global Belimumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Belimumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Belimumab Market Challenges
Table 22. Global Belimumab Sales by Type (Kilotons)
Table 23. Global Belimumab Market Size by Type (M USD)
Table 24. Global Belimumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Belimumab Sales Market Share by Type (2019-2024)
Table 26. Global Belimumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Belimumab Market Size Share by Type (2019-2024)
Table 28. Global Belimumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Belimumab Sales (Kilotons) by Application
Table 30. Global Belimumab Market Size by Application
Table 31. Global Belimumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Belimumab Sales Market Share by Application (2019-2024)
Table 33. Global Belimumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Belimumab Market Share by Application (2019-2024)
Table 35. Global Belimumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Belimumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Belimumab Sales Market Share by Region (2019-2024)
Table 38. North America Belimumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Belimumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Belimumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Belimumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Belimumab Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline Belimumab Basic Information
Table 44. GlaxoSmithKline Belimumab Product Overview
Table 45. GlaxoSmithKline Belimumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Belimumab SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Global Belimumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Belimumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Belimumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Belimumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Belimumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Belimumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Belimumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Belimumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Belimumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Belimumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Belimumab Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Belimumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Belimumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Belimumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Belimumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Belimumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Belimumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Belimumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Belimumab Market Size (M USD), 2019-2030
Figure 5. Global Belimumab Market Size (M USD) (2019-2030)
Figure 6. Global Belimumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Belimumab Market Size by Country (M USD)
Figure 11. Belimumab Sales Share by Manufacturers in 2023
Figure 12. Global Belimumab Revenue Share by Manufacturers in 2023
Figure 13. Belimumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Belimumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Belimumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Belimumab Market Share by Type
Figure 18. Sales Market Share of Belimumab by Type (2019-2024)
Figure 19. Sales Market Share of Belimumab by Type in 2023
Figure 20. Market Size Share of Belimumab by Type (2019-2024)
Figure 21. Market Size Market Share of Belimumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Belimumab Market Share by Application
Figure 24. Global Belimumab Sales Market Share by Application (2019-2024)
Figure 25. Global Belimumab Sales Market Share by Application in 2023
Figure 26. Global Belimumab Market Share by Application (2019-2024)
Figure 27. Global Belimumab Market Share by Application in 2023
Figure 28. Global Belimumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Belimumab Sales Market Share by Region (2019-2024)
Figure 30. North America Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Belimumab Sales Market Share by Country in 2023
Figure 32. U.S. Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Belimumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Belimumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Belimumab Sales Market Share by Country in 2023
Figure 37. Germany Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Belimumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Belimumab Sales Market Share by Region in 2023
Figure 44. China Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Belimumab Sales and Growth Rate (Kilotons)
Figure 50. South America Belimumab Sales Market Share by Country in 2023
Figure 51. Brazil Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Belimumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Belimumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Belimumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Belimumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Belimumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Belimumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Belimumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Belimumab Sales Forecast by Application (2025-2030)
Figure 66. Global Belimumab Market Share Forecast by Application (2025-2030)
